StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Share Repurchase Authorization by Year

Share Repurchase Authorization — Remaining dollar authority ($M) ($M)

Pfizer Share Repurchase Authorization: $3,300M in FY2025, unchanged from a year earlier. That is the lowest of the 11 years on record here.

Latest, FY2025
3,300
Period ended Dec 31, 2025
Change on a year earlier
0.0%
3,300 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Equity Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare Repurchase Authorization — Remaining dollar authority ($M) ($M)Year on yearSource
FY2025Dec 31, 20253,3000.0%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 20243,3000.0%Form 10-K (filed 2025-02-27) ↗
FY2023Dec 31, 20233,3000.0%Form 10-K (filed 2024-02-22) ↗
FY2022Dec 31, 20223,300-37.7%Form 10-K (filed 2023-02-23) ↗
FY2021Dec 31, 20215,3000.0%Form 10-K (filed 2022-02-24) ↗
FY2020Dec 31, 20205,3000.0%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 20195,300-62.7%Form 10-K (filed 2020-02-27) ↗
FY2018Dec 31, 201814,200-13.4%Form 10-K (filed 2019-02-28) ↗
FY2017Dec 31, 201716,400+43.9%Form 10-K (filed 2018-02-22) ↗
FY2016Dec 31, 201611,400-30.5%Form 10-K (filed 2017-02-23) ↗
FY2015Dec 31, 201516,400–Form 10-K (filed 2016-02-29) ↗

Cite this data

StockData. (2026). Pfizer Share Repurchase Authorization ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/repurchase-rem-ann

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.